PUMA BIOTECHNOLOGY, INC. (PBYI) Net margin 2017–2025
PUMA BIOTECHNOLOGY, INC. (PBYI) net profit margin by fiscal year — reported net income divided by reported revenue.
13.6%FY2025 · since FY2017: -1054.6% → 13.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 13.6% | +0.5 pp |
| FY2024 | 13.1% | +4.0 pp |
| FY2023 | 9.2% | +9.2 pp |
| FY2022 | 0.0% | -11.5 pp |
| FY2021 | 11.5% | +38.2 pp |
| FY2020 | -26.7% | +1.1 pp |
| FY2019 | -27.8% | +17.5 pp |
| FY2018 | -45.3% | +1009.3 pp |
| FY2017 | -1054.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice